Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study

NCT00878813 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT00878813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00878813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2011
Enrollment
1,102 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, transient ischemic attack